A novel nanoparticulate formulation of arsenic trioxide with enhanced therapeutic efficacy in a murine model of breast cancer.
about
Estrogen-dependent sushi domain containing 3 regulates cytoskeleton organization and migration in breast cancer cellsThe Gynecologist Has a Unique Role in Providing Oncofertility Care to Young Cancer PatientsToward precision medicine for preserving fertility in cancer patients: existing and emerging fertility preservation options for womenNano-encapsulation of arsenic trioxide enhances efficacy against murine lymphoma model while minimizing its impact on ovarian reserve in vitro and in vivoRecent advances in arsenic trioxide encapsulated nanoparticles as drug delivery agents to solid cancersComparison of optical and power Doppler ultrasound imaging for non-invasive evaluation of arsenic trioxide as a vascular disrupting agent in tumors.Fertility preservation in women with cancer.Rapid reduction in breast cancer mortality with inorganic arsenic in drinking waterMetals and breast cancer: risk factors or healing agents?Vascular disrupting agent arsenic trioxide enhances thermoradiotherapy of solid tumors.3D tumor tissue analogs and their orthotopic implants for understanding tumor-targeting of microenvironment-responsive nanosized chemotherapy and radiation.Targeted nanoparticles for image-guided treatment of triple-negative breast cancer: clinical significance and technological advancesMethylated arsenic metabolites bind to PML protein but do not induce cellular differentiation and PML-RARα protein degradationTriggered release of pharmacophores from [Ni(HAsO₃)]-loaded polymer-caged nanobin enhances pro-apoptotic activity: a combined experimental and theoretical study.The many spaces of uPAR: delivery of theranostic agents and nanobins to multiple tumor compartments through a single targetArsenic trioxide inhibits viability of pancreatic cancer stem cells in culture and in a xenograft model via binding to SHH-GliThe potential role of nanotechnology in therapeutic approaches for triple negative breast cancer.Triple Negative Breast Cancer: Nanosolutions for a Big Challenge.Urokinase plasminogen activator system-targeted delivery of nanobins as a novel ovarian cancer therapy.Anticancer activity of small-molecule and nanoparticulate arsenic(III) complexes.Radiation-enhanced therapeutic targeting of galectin-1 enriched malignant stroma in triple negative breast cancer.Integrative nanomedicine: treating cancer with nanoscale natural products.Tumor microenvironment and nanotherapeutics.Antibody-based PET of uPA/uPAR signaling with broad applicability for cancer imaging.Phenylarsine Oxide Can Induce the Arsenite-Resistance Mutant PML Protein Solubility ChangesDevelopment of novel therapeutics targeting the urokinase plasminogen activator receptor (uPAR) and their translation toward the clinic.Targeting mitochondrial function for the treatment of breast cancer.The combination of arsenic and cryptotanshinone induces apoptosis through induction of endoplasmic reticulum stress-reactive oxygen species in breast cancer cells.Polymer-caged nanobins for synergistic cisplatin-doxorubicin combination chemotherapy.PML promotes metastasis of triple-negative breast cancer through transcriptional regulation of HIF1A target genes.Multidrug resistance protein 1 (ABCC1) confers resistance to arsenic compounds in human myeloid leukemic HL-60 cells.Toxic elements as biomarkers for breast cancer: a meta-analysis study.Intrinsic and Stable Conjugation of Thiolated Mesoporous Silica Nanoparticles with Radioarsenic.Bone-targeting nanoparticle to co-deliver decitabine and arsenic trioxide for effective therapy of myelodysplastic syndrome with low systemic toxicity.
P2860
Q24319134-0478CBF1-D1CB-4DC6-94C5-3C5F365170F8Q24596913-358F60CE-7381-4751-BACF-4D6AD61E06E7Q26771979-B83662EC-FC57-4BE0-942A-4F9757775765Q28488457-43460426-DF86-4784-8FA7-39E87C45C58EQ33768666-DA596638-34B4-4B94-A2C2-88BA0FF60D25Q34430810-54DC2F3A-2AE1-4D3E-B74E-760EA5FD9CEEQ34729392-75A30235-8E33-4921-8871-FE3C5935300CQ34866709-F4626FFF-FB64-45F2-995C-58E3690B9286Q35127590-A5155007-A1D0-4955-AA55-C4DF622BAE3AQ35681405-ABC3A572-8040-4958-8CE2-F6E4F085FFB9Q35994548-E24041A8-4F3B-471A-AE9A-5E5C58F6F847Q36157045-6AF54FD5-AFCA-42C9-8024-EDC60713AFBCQ36413252-2CAF3F5D-45DB-4D6B-8833-BC45B630E6C6Q36831950-EF0B5E4D-D58D-41B3-913A-09DB0841D70DQ36997621-B117A9C6-BF86-4643-BE6A-0008B5E37D39Q37120649-D35D6E7C-676C-402A-9F27-7A534250B7ECQ37304764-0C427A1A-7D33-43E1-B31D-4495ED2F3040Q37422972-EA7FD6EC-7ACF-4707-BBF4-75E48BE4E83FQ37451733-B6751A6E-B640-415F-8D06-1ECAA0CB658CQ37486703-082B7CFB-3CFA-4591-B01C-036CAD2252ECQ37520289-22C18B51-5A75-4024-A891-7B46EC982DBFQ37578847-FF504402-5C45-4F3D-8182-F1CFAF26D42AQ37632757-3902FC9E-AEA0-4DAE-A38F-1AE4EE664196Q37687496-347B8EFE-E0AE-43F7-BEC5-7C370482852FQ37690635-E6B440B9-172D-46A4-9FC0-751A2C073C4DQ37895294-0DED559E-4973-4880-B7B4-56C66F6A1E06Q38264534-02AFB4C8-32E5-4E7E-9647-1139B5D50082Q38938902-C90632D7-6B09-4DEE-8761-E8E48EE516D7Q39631781-3BA102CE-0FAD-4683-B211-E2BD0B5C7087Q42177054-04C22C2B-BEEA-44C8-AF38-BA9F5F90F68BQ42715412-B82016C9-7035-4C8C-A347-C38DC7914531Q47549876-FF006B3B-7969-4B88-B2E1-A802AF62A9BBQ48272615-549611D1-1BAE-407A-AB17-0F3648AABA16Q50085294-F50E3084-D536-49D5-B37A-5391447396D5
P2860
A novel nanoparticulate formulation of arsenic trioxide with enhanced therapeutic efficacy in a murine model of breast cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A novel nanoparticulate formul ...... murine model of breast cancer.
@ast
A novel nanoparticulate formul ...... murine model of breast cancer.
@en
A novel nanoparticulate formul ...... murine model of breast cancer.
@nl
type
label
A novel nanoparticulate formul ...... murine model of breast cancer.
@ast
A novel nanoparticulate formul ...... murine model of breast cancer.
@en
A novel nanoparticulate formul ...... murine model of breast cancer.
@nl
prefLabel
A novel nanoparticulate formul ...... murine model of breast cancer.
@ast
A novel nanoparticulate formul ...... murine model of breast cancer.
@en
A novel nanoparticulate formul ...... murine model of breast cancer.
@nl
P2093
P2860
P1476
A novel nanoparticulate formul ...... murine model of breast cancer
@en
P2093
Anil K Patri
Elden P Swindell
Haimei Chen
Meera R Raja
Stephan T Stern
Thomas V O'Halloran
Vamsi Parimi
Vincent L Cryns
P2860
P304
P356
10.1158/1078-0432.CCR-10-0068
P407
P577
2010-06-02T00:00:00Z